Microscopic and metabolomics analysis of the anti-Listeria activity of natural and engineered cruzioseptins
Abstract
No abstract availableKeywords
Funding Information
- FAPESP (2020/15599-9, 2018/25511-1, 2022/04841-9, 2022/02936-2)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- CNPq (312923/2020-1, 408783/2021-4)
This publication has 49 references indexed in Scilit:
- Inspiration from cruzioseptin-1: membranolytic analogue with improved antibacterial propertiesAmino Acids, 2023
- Deciphering the Limitations and Antibacterial Mechanism of CruzioseptinsInternational Journal of Peptide Research and Therapeutics, 2022
- Novel antimicrobial cruzioseptin peptides extracted from the splendid leaf frog, Cruziohyla calcariferAmino Acids, 2021
- Multiple action mechanism and in vivo antimicrobial efficacy of antimicrobial peptide Jelleine‐IJournal of Peptide Science, 2020
- Antibacterial mechanism of brevilaterin B: an amphiphilic lipopeptide targeting the membrane of Listeria monocytogenesApplied Microbiology and Biotechnology, 2020
- Antibacterial effects of a polypeptide-enriched extract of Rana chensinensis via the regulation of energy metabolismMolecular Biology Reports, 2020
- Design of novel analogues of short antimicrobial peptide anoplin with improved antimicrobial activityJournal of Peptide Science, 2014
- Application of antimicrobial peptides in agriculture and food industryWorld Journal of Microbiology and Biotechnology, 2009
- Effects of net charge and the number of positively charged residues on the biological activity of amphipathic α‐helical cationic antimicrobial peptidesPeptide Science, 2008
- Dual mode of action of Bac7, a proline-rich antibacterial peptideBiochimica et Biophysica Acta (BBA) - General Subjects, 2006